Ovine desipramine antibody fragments reverse desipramine cardiovascular toxicity in the rat

被引:20
|
作者
Dart, RC [1 ]
Sidki, A [1 ]
Sullivan, JB [1 ]
Egen, NB [1 ]
Garcia, RA [1 ]
机构
[1] UNIV ARIZONA,DEPT SURG,SECT EMERGENCY MED,TUCSON,AZ
关键词
D O I
10.1016/S0196-0644(96)70265-2
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objective: To develop a model of severe desipramine cardiovascular toxicity and to determine whether partial neutralization of the antigen by desipramine-specific Fab antibody fragments ameliorates its cardiovascular effects. Methods: We administered desipramine to rats until the QRS interval tripled in duration and mean arterial pressure (MAP) was less than 100 mm Hg. Animals were then assigned to one of six groups: (1) no treatment, (2) normal saline solution control treatment (.9% NaCl infusion equal to the volume of Fab infusion), (3) nonimmune Fab control treatment (infusion of Fab equal to that in the 9.6% neutralization treatment), (4) 9.6% desipramine Fab (infusion of ovine desipramine Fab equal to 9.6% of an equimolar neutralization), (5) 19.2% desipramine Fab, and (6) 30.0% desipramine Fab. Results: QRS-interval duration, heart rate, and MAP were recorded for 60 minutes. Animals in groups 1 through 3 demon strated slow and incomplete improvement. Animals in groups 4 through 6 showed improvement in QRS-interval duration and heart rate within 4 minutes (P<.05) compared with untreated animals. A dose-response relationship was evident; animals given the highest dose of desipramine-specific Fab showed the greatest improvement. Conclusion: Partial neutralization of desipramine by specific Fab fragments produces rapid improvement of QRS-interval duration and heart rate in a rat model of severe desipramine toxicity.
引用
收藏
页码:309 / 315
页数:7
相关论文
共 50 条
  • [31] REDUCTION OF DESIPRAMINE CARDIOTOXICITY AND PROLONGATION OF SURVIVAL IN RATS WITH THE USE OF POLYCLONAL DRUG-SPECIFIC ANTIBODY FAB FRAGMENTS
    PENTEL, PR
    SCARLETT, W
    ROSS, CA
    LANDON, J
    SIDKI, A
    KEYLER, DE
    ANNALS OF EMERGENCY MEDICINE, 1995, 26 (03) : 334 - 341
  • [32] DETERMINATION OF THE INVIVO ANTIGEN-ANTIBODY AFFINITY CONSTANT FROM THE REDISTRIBUTION OF DESIPRAMINE IN RATS FOLLOWING ADMINISTRATION OF A DESIPRAMINE-SPECIFIC MONOCLONAL-ANTIBODY
    POND, SM
    PENTEL, PR
    KEYLER, DE
    WINZOR, DJ
    BIOCHEMICAL PHARMACOLOGY, 1991, 41 (03) : 473 - 476
  • [33] Cardiovascular effects of desipramine in children and adults during exercise testing
    Waslick, BD
    Walsh, BT
    Greenhill, LL
    Giardina, EGV
    Sloan, RP
    Bigger, JT
    Bilich, K
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1999, 38 (02): : 179 - 186
  • [34] Desipramine toxicity with terbinafine (vol 159, pg 492, 2002)
    O'Reardon, JP
    AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (06): : 1076 - 1076
  • [35] Effect of acute desipramine treatment on immunological parameters in the rat
    Connor, TJ
    Kelly, JP
    Leonard, BE
    MEDICAL SCIENCE RESEARCH, 1997, 25 (03): : 209 - 211
  • [36] Effect of desipramine on spontaneous arterial pressure oscillations in the rat
    Bertram, D
    Barrès, C
    Julien, C
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 378 (03) : 265 - 271
  • [37] EFFECTS OF DESIPRAMINE AND COCAINE ON SYMPATHETIC RESPONSES IN PITHED RAT
    GLOVER, AB
    MCCULLOCH, MW
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1970, 22 (10) : 789 - +
  • [38] PLASMA CONCENTRATIONS AND CARDIOTOXIC EFFECTS OF DESIPRAMINE AND PROTRIPTYLINE IN RAT
    BIANCHETTI, G
    BONACCORSI, A
    CHIODAROLI, A
    FRANCO, R
    GARATTINI, S
    GOMENI, R
    MORSELLI, PL
    BRITISH JOURNAL OF PHARMACOLOGY, 1977, 60 (01) : 11 - 19
  • [39] CARDIOVASCULAR EFFECTS OF DESIPRAMINE IN CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT DISORDER
    BIEDERMAN, J
    GASTFRIEND, D
    JELLINEK, MS
    GOLDBLATT, A
    JOURNAL OF PEDIATRICS, 1985, 106 (06): : 1017 - 1020